CH
NVIV

CVI Holdings’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

CVI Holdings’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-99
Closed -$116K – 93
2019
Q1 		$116K Sell
99
-147
-60% -$171K 0.11% 34
2018
Q4 		$279K Buy
246
+150
+156% +$218K 0.62% 16
2018
Q3 		$146K Sell
96
-113
-54% -$167K 0.24% 24
2018
Q2 		$266K Buy
+209
New +$1.15M 0.33% 28

Other funds holding NVIV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Paulson Wealth Management Wheaton, Illinois $427M AUM 16.36% 1-Year Est. Return

CVI Holdings's NVIV Position: Q2 2019 in Review

CVI Holdings sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2019, closing a stake of 99 shares — an estimated $116K sold.

CVI Holdings first reported a position in NVIV in Q2 2018 and held it in 4 quarters. The position peaked at $279K in Q4 2018. 15 funds tracked by Wall St. Rank hold NVIV as of Q2 2019.

  • CVI Holdings reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2019 after selling out during the quarter.
  • CVI Holdings sold 99 InVivo Therapeutics Holdings Corp shares in Q2 2019, an estimated $116K.
  • CVI Holdings first reported a position in InVivo Therapeutics Holdings Corp in Q2 2018 and held it in 4 quarters.
  • CVI Holdings's InVivo Therapeutics Holdings Corp position peaked at $279K in Q4 2018.
  • 15 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2019.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.